Treatment Outcomes of Pulpotomy Versus Pulpectomy in Vital Primary Molars Diagnosed With Irreversible Pulpitis
Launched by QATAR UNIVERSITY · Mar 25, 2025
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different dental treatments, pulpotomy and pulpectomy, to see which one works better for treating young children with a condition called irreversible pulpitis, which means that the nerve inside a tooth is damaged and causing pain. Pulpotomy is a simpler and quicker procedure that can be easier for kids to handle, while pulpectomy is the more traditional approach. The researchers want to find out if pulpotomy can effectively treat the problem while making the experience more comfortable for young patients.
To be eligible for this trial, children aged between four and nine years old who are healthy and cooperative may participate, as long as they have a primary molar (a back tooth) showing symptoms of irreversible pulpitis, but without signs of infection. Parents should be willing to have their child's tooth covered with a crown after treatment. Participants in the trial can expect to receive one of the two treatments and will be part of a study that aims to improve dental care for children in the future. This trial is not yet recruiting participants, so there is no immediate action needed.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Healthy (ASA I and II) co-operative children (Frankl Scale + and ++) between the ages of four and nine years.
- • 2. Participants have symptoms typical of irreversible pulpitis in one of the primary molars.
- • 3. The pulp of the affected primary molar is vital.
- • 4. Radicular pulp health is confirmed by attainment of radicular pulp haemostasis within 6 minutes of coronal pulp amputation.
- • 5. The affected primary molars can be restored with full coverage stainless steel crowns.
- • 6. Any physiologic root resorption, if present, is less than ⅓ the root length.
- Exclusion Criteria:
- • 1. Clinical examination of affected primary molar reveals signs of pulpal infection (e.g. pathologic tooth mobility, parulis/fistula, or soft tissue swelling).
- • 2. Pre-operative periapical radiograph suggests presence of periapical radiolucency or pathologic root resorption.
- • 3. Visual examination of pulp tissue after deroofing reveals signs of necrosis (e.g. avascular/minimally bleeding pulp tissue or yellowish necrotic areas/purulent exudate).
- • 4. Signs of extensive radicular pulp inflammation i.e., root pulp bleeding continues even after 6-min.
- • 5. Parents not willing to place full coverage crowns post-treatment.
- • 6. Clinical diagnosis of irreversible pulpitis between two adjacent primary molars is not sharply defined.
- • 7. Unable to perform clinical procedure under rubber dam
About Qatar University
Qatar University is a leading academic institution dedicated to advancing research and innovation across various fields, including healthcare and clinical sciences. As a clinical trial sponsor, Qatar University leverages its robust academic resources and expertise to conduct rigorous research aimed at improving health outcomes and addressing public health challenges. The university fosters collaboration among multidisciplinary teams, promoting the integration of cutting-edge scientific knowledge with practical applications. Through its commitment to ethical research practices and adherence to regulatory standards, Qatar University aims to contribute meaningful insights to the global medical community while enhancing the quality of care for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Nebu Philip, MDS, PhD
Principal Investigator
Qatar University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported